Danaher schedules third-quarter results: Danaher stock is valued at USD 157.8 billion

Published on 10/20/2026 at 11:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Danaher reports third-quarter results on October 21, 2026. Danaher stock trades at EUR 201.95 on October 20, 2026 with USD 157.8 billion value.

Upcoming results and growth guidance

Danaher scheduled its third-quarter report for October 21, 2026.
Management guided to 3-4 percent core revenue growth for fiscal year 2026.
Danaher stock trades at EUR 201.95 at 11:34 a.m. CEST at Lang & Schwarz on October 20, 2026.
TD Cowen raised its price target to USD 255.00 on October 13, 2026.

Extreme Makroaufnahme einer leuchtend blauen DNA-Doppelhelix auf dunklem Hintergrund mit Bokeh — Danaher Corp. DNA-Doppelhelix US2358511028 in leuchtendem Blau als extreme Makroaufnahme molekularer Struktur, Illustration mit AI erstellt.

Danaher Corp. (ISIN US2358511028) was trading at EUR 201.95 at Lang & Schwarz at 11:34 a.m. CEST on October 20, 2026, while its market capitalization stood at USD 157.8 billion. The company is due to report third-quarter results on October 21, a test of whether its recovery in life sciences and diagnostics is broadening.

Danaher scheduled the report for before the US market opens, with the earnings call set for 8:00 a.m. ET. The prior quarter provides a demanding benchmark: second-quarter sales were USD 6.3 billion, core revenue rose 3.00 percent year over year, and adjusted operating profit margin reached 27.10 percent, according to Yahoo Finance.

What is Danaher guiding for 2026?

The company entered the report with full-year 2026 core revenue growth guidance of 3.00 percent to 4.00 percent. Its adjusted diluted earnings-per-share guidance was raised to USD 8.45-8.60 from USD 8.35-8.55 after the second-quarter performance and the earlier completion of the Masimo acquisition, the earnings-call transcript states.

Three milestones shape the setup

On October 1, 2026, Julie Sawyer Montgomery assumed the roles of president and chief executive officer, according to Danaher. On October 14, 2026, the company announced an artificial-intelligence collaboration with NVIDIA, bringing together NVIDIA technologies and Danaher's laboratory workflows. The October 21 results date is the third milestone.

Analyst expectations have also moved higher. According to Benzinga, TD Cowen raised its target from USD 236.00 to USD 255.00 on October 13, 2026. The same report cited consensus expectations of USD 6.56 billion in third-quarter revenue and USD 1.92 in earnings per share.

What comes next for Danaher?

The next scheduled dates are the third-quarter report on October 21, 2026 and the USD 0.40-per-share dividend payment on October 30, 2026, both listed in Danaher's 2026 release calendar. The immediate investor question is whether reported growth can validate the improved full-year earnings range while bioprocessing shipment timing remains a variable.

Stock and valuation context

Danaher trades on the NYSE under ticker DHR. The primary-market quote was USD 224.43 at 4:02 p.m. ET on October 19, 2026, while the 52-week range was USD 160.93 to USD 242.80. The current euro quotation from Lang & Schwarz was EUR 201.95 at 11:34 a.m. CEST on October 20, 2026.

The further course of trading is shown by the continuously updated real-time quote of Danaher stock.